Page last updated: 2024-12-07

phenylalanyl-phenylalanyl-phenylalanine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Phenylalanyl-phenylalanyl-phenylalanine, also known as Phe-Phe-Phe or tri-phenylalanine, is a tripeptide composed of three phenylalanine amino acid residues. It is a relatively simple peptide that has been studied for its potential biological activity.

Research has investigated Phe-Phe-Phe for its potential role in:

* **Protein Aggregation:** Phe-Phe-Phe is known to promote protein aggregation, a process that can lead to the formation of amyloid fibrils. This is because the hydrophobic phenylalanine residues can interact with each other, leading to the formation of stable aggregates.
* **Cell Signaling:** Some studies suggest that Phe-Phe-Phe may have a role in cell signaling. It has been found to interact with certain cell surface receptors, and it is thought to be involved in the regulation of cellular processes such as growth and differentiation.
* **Drug Delivery:** Phe-Phe-Phe has been investigated as a potential drug delivery agent. It can be used to encapsulate and deliver drugs to specific cells or tissues.

While research on Phe-Phe-Phe is ongoing, it has shown promise in areas such as protein aggregation, cell signaling, and drug delivery. However, more studies are needed to fully understand its biological activity and potential therapeutic applications.'

phenylalanyl-phenylalanyl-phenylalanine: RN given refers to all (L)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID75739
CHEMBL ID420482
CHEBI ID161777
SCHEMBL ID8082492
MeSH IDM0122153

Synonyms (15)

Synonym
l-phenylalanine, n-(n-l-phenylalanyl-l-phenylalanyl)-
tri-l-phenylalanine
phenylalanyl-phenylalanyl-phenylalanine
CHEBI:161777
(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoic acid
phe-phe-phe
2578-81-6
CHEMBL420482
l-phenylalanyl-l-phenylalanyl-l-phenylalanine
SCHEMBL8082492
h-phe-phe-phe-oh
mfcd00037261
phenylalanylphenylalanylphenylalanine
DTXSID10948646
n-{2-[(2-amino-1-hydroxy-3-phenylpropylidene)amino]-1-hydroxy-3-phenylpropylidene}phenylalanine
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
oligopeptideA peptide containing a relatively small number of amino acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID18749Relativity constant at a substrate concentration of 218 uM2003Bioorganic & medicinal chemistry letters, Oct-06, Volume: 13, Issue:19
The stability of pseudopeptides bearing sulfoximines as chiral backbone modifying element towards proteinase K.
AID526896Binding affinity to HIV1 TAR RNA2010Bioorganic & medicinal chemistry, Nov-01, Volume: 18, Issue:21
Polyamide amino acids trimers as TAR RNA ligands and anti-HIV agents.
AID526901Inhibition of HIV1 Tat/TAR interaction at 1 to 400 uM by FRET based competition assay2010Bioorganic & medicinal chemistry, Nov-01, Volume: 18, Issue:21
Polyamide amino acids trimers as TAR RNA ligands and anti-HIV agents.
AID781326pKa (acid-base dissociation constant) as determined by Avdeef ref: DOI: 10.1002/047145026X2014Pharmaceutical research, Apr, Volume: 31, Issue:4
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
AID162715Amount of proteinase K required to release folin positive amino acids at a substrate concentration of 304 uM2003Bioorganic & medicinal chemistry letters, Oct-06, Volume: 13, Issue:19
The stability of pseudopeptides bearing sulfoximines as chiral backbone modifying element towards proteinase K.
AID18531Rate constant for the compound at a substrate concentration of 218 uM was determined2003Bioorganic & medicinal chemistry letters, Oct-06, Volume: 13, Issue:19
The stability of pseudopeptides bearing sulfoximines as chiral backbone modifying element towards proteinase K.
AID24001Half-life period at a substrate concentration of 218 uM was determined2003Bioorganic & medicinal chemistry letters, Oct-06, Volume: 13, Issue:19
The stability of pseudopeptides bearing sulfoximines as chiral backbone modifying element towards proteinase K.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (12.50)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's5 (62.50)24.3611
2020's1 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.50

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.50 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.70 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.50)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]